1Department of Radiation Oncology, Hanyang University Hospital, Seoul, Korea
2Department of Health Policy and Management, Seoul National University College of Medicine, Seoul, Korea
3Institute of Health Policy and Management, Medical Research Center, Seoul National University, Seoul, Korea
Copyright © 2018 by the Korean Cancer Association
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
KCCR, Korea Central Cancer Registry (source: http://www.ncc.re.kr/cancerStatsList.ncc?searchKey=total&searchValue=&pageNum=1) [12].
Reimbursement code |
Name of radical surgery | |
---|---|---|
LND(+) | LND(‒) | |
QA921 | Q2921 | Rectal and sigmoid resection–anterior resection |
QA922 | Q2922 | Rectal and sigmoid resection–low anterior resection |
QA923 | Q2923 | Rectal and sigmoid resection (abdomino-perineal resection) |
QA924 | Q2924 | Rectal and sigmoid resection–abdominal pull through operation |
QA925 | Q2925 | Total coloprotectomy–with ileostomy |
QA926 | Q2926 | Total coloprotectomy (with ileal pouch-anal anastomosis) |
Reimbursement code | Name of radiotherapy |
---|---|
HD061 | 3-Dimensional conformal therapy |
HZ271 | Intensity modulated radiation therapy |
HD110 | Fractionated stereotactic radiotherapy |
HD111 | Body stereotactic radiosurgery–linear accelerator |
HD121 | Proton therapy |
HD211 | Body stereotactic radiosurgery–cyber knife |
HD051 | Teletherapy–low energy–single port |
HD052 | Teletherapy–middle energy–single port |
HD053 | Teletherapy–high energy–single port |
HD054 | Teletherapy–low energy–paralled opposed ports |
HD055 | Teletherapy–middle energy–paralled opposed ports |
HD056 | Teletherapy–high energy–paralled opposed ports |
HD057 | Rotational irradiation–low energy |
HD058 | Rotational irradiation–middle energy |
HD059 | Rotational irradiation–high energy |
Characteristic | No. of institutions |
---|---|
Region | |
Seoul | 25 |
Incheon–Gyeonggi-do | 20 |
Daejeon–Chungcheong-do | 7 |
Gwangju–Jeolla-do–Jeju-do | 8 |
Busan–Ulsan–Gyeongsangnam-do | 11 |
Daegu–Gyeongsangbuk-do | 8 |
Gangwon-do | 4 |
Tertiary hospital | |
Yes | 42 |
No | 41 |
No. of hospital beds | |
2,000-2,499 | 1 |
1,500-1,999 | 3 |
1,100-1,499 | 4 |
900-1,099 | 7 |
700-899 | 27 |
500-699 | 30 |
≤ 499 | 11 |
No. of radiation oncologists | |
≥ 6 | 6 |
4-5 | 10 |
3 | 21 |
2 | 25 |
1 | 21 |
No. of RT cases for 12 years | |
≥ 1,000 | 6 |
500-999 | 0 |
300-499 | 7 |
200-299 | 10 |
100-199 | 22 |
50-99 | 12 |
10-49 | 21 |
1-9 | 5 |
Total | 83 |
Characteristic | 2005-2006 | 2007-2008 | 2009-2010 | 2011-2012 | 2013-2014 | 2015-2016 |
---|---|---|---|---|---|---|
Region | ||||||
Seoul | 373/889 (42.0) | 641/1,087 (59.0) | 924/1,326 (69.7) | 1,112/1,545 (72.0) | 967/1,269 (76.2) | 862/1,095 (78.7) |
Incheon–Gyeonggi-do | 359/577 (62.2) | 443/653 (67.8) | 444/621 (71.5) | 542/755 (71.8) | 551/694 (79.4) | 645/749 (86.1) |
Daejeon–Chungcheong-do | 51/153 (33.3) | 91/150 (60.7) | 113/142 (79.6) | 148/169 (87.6) | 104/119 (87.4) | 123/144 (85.4) |
Gwangju–Jeolla-do–Jeju-do | 43/108 (39.8) | 122/210 (58.1) | 242/319 (75.9) | 232/329 (70.5) | 219/332 (66.0) | 267/324 (82.4) |
Busan–Ulsan–Gyeongsangnam-do | 119/273 (43.6) | 80/218 (36.7) | 157/259 (60.6) | 204/311 (65.6) | 225/337 (66.8) | 184/265 (69.4) |
Daegu–Gyeongsangbuk-do | 137/213 (64.3) | 161/221 (72.9) | 158/211 (74.9) | 72/126 (57.1) | 98/127 (77.2) | 87/104 (83.7) |
Gangwon-do | 6/26 (23.1) | 22/44 (50.0) | 45/87 (51.7) | 58/80 (72.5) | 79/93 (84.9) | 53/73 (72.6) |
Tertiary hospital | ||||||
Yes | 821/1,756 (46.8) | 1,166/1,980 (58.9) | 1,700/2,421 (70.2) | 1,928/2,680 (71.9) | 1,716/2,267 (75.7) | 1,648/2,049 (80.4) |
No | 267/483 (55.3) | 394/603 (65.3) | 383/544 (70.4) | 440/635 (69.3) | 527/704 (74.9) | 573/705 (81.3) |
No. of hospital bed | ||||||
≥ 1,500 | 318/749 (42.5) | 528/855 (61.8) | 747/1,025 (72.9) | 813/1,071 (75.9) | 620/772 (80.3) | 532/644 (82.6) |
1,100-1,499 | 95/153 (62.1) | 130/188 (69.1) | 163/231 (70.6) | 206/298 (69.1) | 197/267 (73.8) | 243/300 (81.0) |
900-1,099 | 104/131 (79.4) | 103/164 (62.8) | 155/213 (72.8) | 195/285 (68.4) | 147/245 (60.0) | 128/199 (64.3) |
700-899 | 335/719 (46.6) | 391/727 (53.8) | 501/761 (65.8) | 592/842 (70.3) | 596/759 (78.5) | 523/654 (80.0) |
500-699 | 226/470 (48.1) | 375/595 (63.0) | 463/653 (70.9) | 481/710 (67.7) | 590/803 (73.5) | 721/863 (83.5) |
≤ 499 | 10/17 (58.8) | 33/54 (61.1) | 54/82 (65.9 | 81/109 (74.3) | 93/125 (74.4) | 74/94 (78.7) |
No. of radiation oncologists | ||||||
≥ 6 | 475/980 (48.5) | 751/1,149 (65.4) | 943/1,269 (74.3) | 984/1,291 (76.2) | 772/957 (80.7) | 715/844 (84.7) |
4-5 | 311/475 (65.5) | 407/595 (68.4) | 516/699 (73.8) | 501/716 (70.0) | 475/681 (69.8) | 561/699 (80.3) |
3 | 203/467 (43.5) | 258/497 (51.9) | 389/571 (68.1) | 507/682 (74.3) | 533/671 (79.4) | 454/553 (82.1) |
2 | 65/245 (26.5) | 101/256 (39.5) | 176/311 (56.6) | 268/439 (61.0) | 331/454 (72.9) | 327/424 (77.1) |
1 | 34/72 (47.2) | 43/86 (50.0) | 59/115 (51.3) | 108/187 (57.8) | 132/208 (63.5) | 164/234 (70.1) |
No. of RT cases for 12 years | ||||||
≥ 1,000 | 496/1,030 (48.2) | 818/1,254 (65.2) | 1,082/1,446 (74.8) | 1,070/1,442 (74.2) | 860/1,105 (77.8) | 859/1,021 (84.1) |
300-499 | 303/405 (74.8) | 299/426 (70.2) | 345/457 (75.5) | 333/464 (71.8) | 354/462 (76.6) | 373/448 (83.3) |
200-299 | 129/334 (38.6) | 217/387 (56.1) | 292/448 (65.2) | 368/451 (81.6) | 339/435 (77.9) | 291/359 (81.1) |
100-199 | 120/343 (35.0) | 161/369 (43.6) | 270/418 (64.6) | 400/612 (65.4) | 464/596 (77.9) | 422/544 (77.6) |
1-99 | 40/127 (31.5) | 65/147 (44.2) | 94/196 (48.0) | 197/346 (56.9) | 226/373 (60.6) | 276/382 (72.3) |
Year | No. of patients |
|
---|---|---|
KCCR | Our study | |
2005-2006 | 17,345 | 2,239 (12.9) |
2007-2008 | 19,170 | 2,583 (13.5) |
2009-2010 | 22,813 | 2,965 (13.0) |
2011-2012 | 25,253 | 3,315 (13.1) |
2013-2014 | 23,833 | 2,971 (12.5) |
Total | 108,414 | 14,073 (13.0) |
LND, lymph node dissection.
Four institutions without any adjuvant radiotherapy (RT) for rectal cancer during study period were excluded. The results were as of year 2016.
Values are presented as the number of patients treated with preoperative radiotherapy/the total number of patients treated with preoperative or postoperative radiotherapy (%).
KCCR, Korea Central Cancer Registry (source: